GÜVEN, D. C. Et Al. 2022. The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors. Cancer Biomarkers , vol.34, no.2 , 189-199.

GÜVEN, D. C., AKTEPE, O. H., Aksun, M. S., Sahin, T. K., KAVGACI, G., Ucgul, E., ... YALÇIN ÇAKIR, F.(2022). The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors. Cancer Biomarkers , vol.34, no.2, 189-199.

GÜVEN, DENİZ Et Al. "The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors," Cancer Biomarkers , vol.34, no.2, 189-199, 2022

GÜVEN, DENİZ C. Et Al. "The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors." Cancer Biomarkers , vol.34, no.2, pp.189-199, 2022

GÜVEN, D. C. Et Al. (2022) . "The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors." Cancer Biomarkers , vol.34, no.2, pp.189-199.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors}, journal={Cancer Biomarkers}, year=2022, pages={189-199} }